Sonic Healthcare (ASX:SHL) share price on watch after 149% profit boost in FY21

After rallying 30% year-to-date, Sonic Healthcare share price will be put to the test after the release of the company's FY21 results.

| More on:
female nurse in scrubs

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) share price will be in the spotlight on Monday after the company released its FY21 full-year results this morning.

Sonic Healthcare share price in focus after bumper profit result

The Sonic Healthcare share price could be a mover following a well-rounded financial performance in FY21. Key highlights include:

What happened for Sonic Healthcare in FY21?

The Sonic Healthcare share price has rallied strongly in FY21, thanks to its resilient base business and active role in combating the COVID-19 pandemic.

The company has performed approximately 30 million COVID-19 PCR tests to date across ~60 Sonic laboratories globally.

The results noted that COVID-19 PCR volumes were lower in the second half of the year versus the first half, but have been increasing post-year end with the spread of the Delta variant.

Its base business revenue (excluding COVID testing) grew 6% compared to FY20 and was up 4% versus FY19.

Sonic Healthcare's EBITDA surged 81%, again enhanced by COVID-19 testing and leveraging existing infrastructure. The company's laboratory businesses across ANZ, USA and Europe contribute approximately 88% of Group revenues, and the company was pleased to highlight a significant improvement in EBITDA margins

EBITDA margins for its Laboratory division increased from 21.3% to 30.8%. At the same time, Sonic Healthcare's medical imaging business reported 24% EBITDA growth and 108 basis points of margin improvement.

Management commentary

Sonic Healthcare's CEO Dr Colin Goldschmidt commented on the results, saying:

As a global healthcare organisation, we have continued to play a major role in combating the COVID19 pandemic, by providing 30 million PCR tests and over 2 million serology tests to date. We are also proud to be the largest non-government provider of COVID-19 vaccinations in Australia.

Goldschmidt also shed light on the company's strategic focus on acquisitions:

In addition to organic growth, Sonic continues to focus on synergistic acquisitions and other growth opportunities, supported by our current record low gearing levels, geographic footprint, leading market positions and brands, and our deeply embedded Medical Leadership culture. We were delighted to recently announce the pending acquisition of Canberra Imaging Group, following on from our move in March 2021 to majority ownership of Epworth Medical Imaging. We are actively considering further acquisition opportunities, as well as bidding for a number of outsourcing contracts.

What's next for Sonic Healthcare?

The Sonic Healthcare share price has rallied strongly this year, up 30% year-to-date.

The company advised that it will not provide earnings guidance for FY22 due to COVID-19 related unpredictability:

"The pandemic has the potential to cause fluctuations in both COVID-19 testing revenues and the base business, although the base business has become increasingly resilient to the impacts of pandemic waves. The underlying growth drivers for healthcare services remain unchanged. Base business fluctuations are also mitigated by geographical and business sector diversity. The COVID-19 Delta variant is currently driving increases in COVID-19 testing revenues."

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Earnings Results

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Earnings Results

Westpac shares on watch amid $6.99b profit and new buyback

Has the big four bank delivered the goods for investors this year? Let's find out.

Read more »

Woman inspecting packages.
Earnings Results

This top 50 ASX stock is diving 5% despite a strong outlook

Investors were looking for more.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices
Earnings Results

Macquarie share price sinks despite $1.6b half year profit and new buyback

How did this investment bank perform during the first half? Let's find out.

Read more »

A woman holds her hand out under a graphic hologram image of a human brain with brightly lit segments and section points.
Earnings Results

Why the BrainChip share price is in the spotlight this week

Today's reaction is in stark contrast to the day of the release.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

2 All Ords ASX healthcare shares making BIG moves on quarterly updates

These two ASX healthcare companies are seeing heavy trading on Thursday.

Read more »

A businesswoman ponders why her boat is sinking in the ocean.
Resources Shares

Lake Resources share price sinks on quarterly cash flow news

Let's take a look at the highlights of the company's Q3 update.

Read more »

Lithium ion batteries
Earnings Results

Needs a recharge: Novonix share price sees red after Q3 earnings

Investors were likely expecting a tad more.

Read more »

chip and tech stocks represented by two computer chips side by side
AI Stocks

Up 237% in 2024, why is the Appen share price racing higher again today?

Investors are bidding up Appen shares again today. But why?

Read more »